CRI Lifetree appoints Craig-Rodriguez and Marcos to leadership team

Friday, September 28, 2012 02:59 PM

CRI Lifetree, a multi-therapeutic early stage research company, has strengthened its early phase leadership with the appointments of Alicia Craig-Rodriguez as chief operating officer and Jose Marcos as East Coast director of clinical operations. 

Craig-Rodriguez has more than 25 years of leadership experience, including 15 years of overseeing the operational, regulatory and quality compliance of more than 1,000 clinical trials. She has led teams in the creation of comprehensive and industry-compliant SOPs, quality management programs and employee training. Prior to joining CRI Lifetree, Craig-Rodriguez served as president of Comprehensive Clinical Development.

Marcos will add 18 years of experience in hands-on phase I expertise to CRI Lifetree’s leadership team. Prior to joining CRI Lifetree, Marcos served as vice president of phase I clinical operations at Comprehensive Clinical Development. During his tenure there, Marcos advanced the operating infrastructure from a single, 36-bed unit to include three state-of-the-art facilities with a bed capacity exceeding 400 beds.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 8

Physicians: Manufacturers, success of clinical trials influence their decision to prescribe biosimilars

Pivotal trial results of Novartis chronic heart failure drug exceed expectations, could set new standard of care

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs